Bile Duct Cancer
Prevention of intrahepatic distant recurrence by transcatheter arterial infusion chemotherapy with platinum agents for stage I/IIhepatocellular carcinoma.
Survival outcomes in resected extrahepatic cholangiocarcinoma: effect of adjuvant radiotherapy in a surveillance, epidemiology, and end results analysis.
Array comparative genomic hybridization identifies novel potential therapeutic targets in cholangiocarcinoma.
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
A microRNA downregulated in human cholangiocarcinoma controls cell cycle through multiple targets involved in the G1/S checkpoint.
A phase II trial of gemcitabine and capecitabine in patients with unresectable or metastatic gallbladder cancer or cholangiocarcinoma: Southwest Oncology Group study S0202.
Metabolic syndrome increases the risk of primary liver cancer in the United States: A population-based case-control study.
Genetics of hepatobiliary carcinogenesis.
The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma.
Risk factors of cholangiocarcinoma.
Oncologic resection for malignant tumors of the liver.
Trefoil factors: tumor progression markers and mitogens via EGFR/MAPK activation in cholangiocarcinoma.
Strong expression of CD133 is associated with increased cholangiocarcinoma progression.
Transarterial Hepatic Yttrium-90 Radioembolization in Patients with Unresectable Intrahepatic Cholangiocarcinoma: Factors Associated with Prolonged Survival.
Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol: a 2-center study.
Hedgehog signaling in cholangiocytes.
Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
Fibrolamellar carcinoma: a review with focus on genetics and comparison to other malignant primary liver tumors.
Simvastatin stimulates apoptosis in cholangiocarcinoma by inhibition of Rac1 activity.
Curcumin suppresses proliferation and induces apoptosis in human biliary cancer cells through modulation of multiple cell signaling pathways
Cancer-associated fibroblasts in intrahepatic cholangiocarcinoma.
Combinative strategy using tamoxifen and other chemotherapeutic drugs for cholangiocarcinoma chemotherapy.
Last Updated on 10/25/2011 2:53:19 PM